Monique Heyninck serves as Vice President, Intellectual Property for Avanir Pharmaceuticals, Inc. She joined the company in 2011 and has responsibility for Avanir’s global IP strategy, including prosecution, licensing, litigation and dispute resolution. She has over 20 years of combined experience in the pharmaceutical and medical device industries.
Prior to joining Avanir, Monique was Vice President, Intellectual Property for Biosensors International Group, Ltd., an interventional cardiology medical device company headquartered in Singapore and with worldwide operations. Prior to Biosensors, Monique worked at several law firms executing patent strategies to advance corporate goals for her various clients. Earlier in her career, Monique worked as an engineer in the Diagnostics Systems Group for Beckman Instruments, Inc. where she assisted in the development and production of various medical diagnostic instruments and was team leader for the reformulation of electrode membranes. Monique also spent several years working for Allergan, Inc. in its Surgical Regulatory Affairs division, where she was responsible for preparing 510(k) submissions, analyzing customer complaints and obtaining European CE Mark certification for Allergan’s surgical products.
Monique earned her J.D. from Loyola Law School, Los Angeles and her Bachelor of Science in Biomedical Engineering and a Master of Science in Electrical Engineering, with an emphasis in electro-optics and electro-physics, both from the University of Southern California. She is a member of the State Bar of California and licensed to practice before the United States Patent and Trademark Office.